Gregory M. Weinhoff - 30 Sep 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Financial Officer
Signature
/s/ Gregory M. Weinhoff
Issuer symbol
CNTA
Transactions as of
30 Sep 2023
Net transactions value
-$75,971
Form type
4
Filing time
03 Oct 2023, 16:56:25 UTC
Previous filing
03 Jul 2023
Next filing
02 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $75,971 -11,742 -4.2% $6.47 268,839 30 Sep 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.